CLINICAL_TRIALS
trial_result
· 2021-08-26
Clinical Trial Update: Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients [Phase 3]
Summary
Phase 3 clinical trial evaluating melatonin to reduce delirium in end-of-life patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fraser Health | Conditions: Delirium | Phase 3 | Status: COMPLETED